• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Verily Launches Healthy at Work Program for COVID-19 Screening & Testing

by Fred Pennic 06/18/2020 Leave a Comment

Verily Launches Healthy at Work Program for COVID-19 Screening & Testing

What You Should Know:

– Verily launches Healthy at Work Program providing ongoing COVID-19 screening and testing for a healthy return to work and school to communities across the nation.

– The Healthy at Work program combines symptom screening, testing services, and data analytics. Employees, students, or others designated to participate in the program can use the online interface to record health symptoms each day.


Today, Verily, an Alphabet company, has announced a new Healthy at Work program, a comprehensive solution aimed at keeping employees and students safe as they begin returning to shared spaces. Healthy at Work follows Verily’s creation of a secure and connected Baseline COVID-19 Testing Program which has tested over 220,000 individuals across 13 states in close collaboration with state and local public health authorities. Additionally, Verily’s Pathfinder suite of information management tools is supporting health systems and hospitals on the frontlines of care.

Secure, End-to-End Digital Framework to Support Safe Return to Work and School

Healthy at Work integrates daily symptom screening, COVID-19 testing, population analytics, and ongoing safety controls, enabling organizations to operationalize their return to work and campus. Healthy at Work provides organizations with screening and testing protocols and public health guidance to expertly adapt plans to match their specific circumstances with the rapidly changing COVID-19 landscape. The program leverages Verily’s software, data science, and clinical expertise, and its scalable COVID-19 testing infrastructure and partnerships. Verily has developed smart COVID-19 testing, which includes symptom screening, physical testing capabilities and return of results through a qualified physician network.

“COVID-19 has accelerated the need for robust, digital tools that can be made broadly accessible for safety and care, as well as adapted to the rapidly changing healthcare landscape,” said Vivian Lee, MD, Ph.D., MBA, president of Verily Health Platforms. “Healthy at Work leverages Verily’s ability to provide a secure, end-to-end digital framework for collection and return of information, and established COVID-19 testing infrastructure to support a safe return to work and school.”

COVID-19 Testing

Employees, students, or others designated to participate in the program can use the online interface to record health symptoms each day. COVID-19 testing is then made available to individuals through various modalities, including mobile test sites, mail home kits, Verily community test sites, or onsite test sites, per their workplace or university guidelines for returning onsite. Employers and administrators have access to centralized analytics to support them in customizing their return to work and campus programs.

Customization Features

Healthy at Work collects, organizes, and analyzes COVID-19-specific health information, enabling organizations to customize the program based on the needs of their population. Healthy at Work data uses include qualifying people to return to shared spaces and helping customers and Verily administer and continuously improve the program.

“Organizations that decide to reopen during this time are facing the challenge of addressing the unique needs of their populations while adhering to local and national guidelines,” said Rob Califf, MD, MACC, Head of Clinical Policy and Strategy for Verily and Google Health. “Our team is focused on understanding the rapidly changing COVID-19 landscape and providing best practices to organizations who aim to optimize safety while returning to work and campus in a planned manner that facilitates adjustment of practice based on timely analysis of data.”

Tagged With: Alphabet, data analytics, google, Health Systems, MD, Public Health, Verily, workplace

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |